We are live on
!
Find out more
WKSWA
White Knight Strategic Wealth Advisors Portfolio holdings
AUM
$119M
1-Year Est. Return
24.94%
This Fund
S&P 500
This Quarter
Est. Return
-3.79%
1 Year Est. Return
+24.94%
3 Year Est. Return
+104.86%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$69.9M
AUM Growth
-$2.53M
(-3.5%)
Cap. Flow
+$881K
Cap. Flow
% of AUM
1.26%
Top 10 Holdings %
Top 10 Hldgs %
54.06%
Holding
67
New
4
Increased
25
Reduced
25
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$644K |
| 2 |
ARK Innovation ETF
ARKK
|
+$614K |
| 3 |
Abbott
ABT
|
+$407K |
| 4 |
Moderna
MRNA
|
+$339K |
| 5 |
VanEck CEF Muni Income ETF
XMPT
|
+$243K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$566K |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$309K |
| 3 |
Salesforce
CRM
|
+$229K |
| 4 |
Blackrock
BLK
|
+$220K |
| 5 |
Invesco QQQ Trust
QQQ
|
+$200K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.44% |
| 2 | Technology | 14.32% |
| 3 | Consumer Discretionary | 13.1% |
| 4 | Healthcare | 11.64% |
| 5 | Communication Services | 6.94% |
Similar funds
HPM
MWM
SF
TCM
KL
CWM
VA
WPM
White Knight Strategic Wealth Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, White Knight Strategic Wealth Advisors held 67 positions worth $69.9M, down 3.5% from $72.4M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
White Knight Strategic Wealth Advisors's Q3 2022 filing shows 4 new, 25 increased, 25 reduced and 5 closed positions. Its largest new stake was Pfizer: 13,246 shares worth $580K. The largest sale was Bristol-Myers Squibb, an estimated $566K.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
- White Knight Strategic Wealth Advisors's largest Q3 2022 buy was Pfizer: 13,246 shares worth $580K.
- White Knight Strategic Wealth Advisors added most to ARK Innovation ETF in Q3 2022, an estimated $614K increase.
- White Knight Strategic Wealth Advisors's biggest Q3 2022 reduction was Innovator US Equity Ultra Buffer ETF March, cutting an estimated $166K.
- White Knight Strategic Wealth Advisors fully exited Bristol-Myers Squibb in Q3 2022, selling an estimated $566K.
- White Knight Strategic Wealth Advisors's ten largest holdings make up 54% of its $69.9M portfolio in Q3 2022.
- White Knight Strategic Wealth Advisors opened 4 new positions and closed 5 in Q3 2022.
- White Knight Strategic Wealth Advisors's portfolio value fell 3.5% quarter-over-quarter to $69.9M.
Based on White Knight Strategic Wealth Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.